AUSTIN SMITH: Open Payments
NPI 1619574639 · MIDDLEBURG HEIGHTS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 30 payments from 11 companies in 2025. Trend: 2023 $592 · 2024 $437 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $114 |
| ABBVIE INC. | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lundbeck LLC | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
Products named: COBENFY, REXULTI, VRAYLAR, Qelbree, TRINTELLIX, Auvelity, CAPLYTA, INGREZZA.
Industry payments across OH — which companies pay providers there.
